Intervention

Dual X-ray Absorptiometry

ClinicalTrials.gov intervention label

Clinical trials8
Recruiting3
Common conditions23
Lead sponsors shown7

Clinical trials

8 shown
Exercise Training for the Improvement of Immune Activity and Treatment Outcomes During Immunotherapy for Non-small Cell Lung Cancer, BOOST TrialNCT06983899 · 2026-01-28
RECRUITING
Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA StudyNCT06039371 · 2024-05-21
RECRUITING
Vitamin D for Prostate Endocrine TherapyNCT05838716 · 2023-12-14
RECRUITING
Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP TrialNCT07466498 · 2026-11-01
NOT_YET_RECRUITING
Semaglutide and Structured Lifestyle Support to Improve Heart and Blood Vessel Health in Postmenopausal Obese Breast Cancer Survivors Taking Aromatase InhibitorsNCT07769047 · 2026-09-01
NOT_YET_RECRUITING
Testing Low Dose Tamoxifen for Invasive Breast Cancer, LoTam TrialNCT06671912 · 2025-02-19
SUSPENDED
Relugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate CancerNCT06129851 · 2023-11-20
NOT_YET_RECRUITING
Quality of Life and Supportive Care Preferences Following Radiation Therapy in Prostate Cancer SurvivorsNCT02704377 · 2016-05-08
COMPLETED

Common conditions

Stage III Prostate Cancer AJCC v82Stage IVB Prostate Cancer AJCC v82Anatomic Stage 0 Breast Cancer AJCC v81Anatomic Stage 1 Breast Cancer AJCC v81Anatomic Stage I Breast Cancer AJCC v81Anatomic Stage II Breast Cancer AJCC v81Anatomic Stage IIA Breast Cancer AJCC v81Anatomic Stage III Breast Cancer AJCC v81Breast Ductal Carcinoma In Situ1Breast Lobular Carcinoma In Situ1Castration-Resistant Prostate Carcinoma1Castration-Sensitive Prostate Adenocarcinoma1Estrogen Receptor-Positive Breast Carcinoma1HER2-Negative Breast Carcinoma1Lung Non-Small Cell Carcinoma1Metastatic Castration-Sensitive Prostate Adenocarcinoma1Metastatic Prostate Adenocarcinoma1Prostate Carcinoma1Stage I Prostate Cancer AJCC v81Stage II Prostate Cancer AJCC v81Stage IIC Prostate Cancer AJCC v81Stage IV Prostate Cancer AJCC v81Stage IVA Prostate Cancer AJCC v81

Trial status mix

NOT_YET_RECRUITING3
RECRUITING3
COMPLETED1
SUSPENDED1

Phase mix

PHASE23
NA2
PHASE32
PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.